Beyond replacing endoscopy: portal hypertension assessment by AI in unresectable HCC
Unresectable hepatocellular carcinoma (HCC) is rarely an isolated oncologic condition. In patients with cirrhosis, tumor control and hepatic reserve are inextricably intertwined, with portal hypertension (PH) potentially shaping both the safe delivery of systemic therapy and the magnitude of its clinical benefit.
Authors
- Francesco Vizzutti (ORCID: https://orcid.org/0000-0002-3014-8968)
- Fabio Marra (ORCID: https://orcid.org/0000-0001-8629-0878)
- Alfredo Vozza (ORCID: https://orcid.org/0000-0002-0843-8248)
Institutions
- University of Florence (IT)
Publication Details
- Journal
- Hepatoma Research
- Published
- 2026-10-27
- DOI
- https://doi.org/10.20517/2394-5079.2026.97
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00